Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2026-04-21 @ 1:32 PM
Study NCT ID:
NCT01239368
Status:
TERMINATED
Last Update Posted:
2019-12-10
First Post:
2010-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
110016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None